IRD

Conviction 42HealthcareScan · Mon, Aug 10, 2026

Shooting star

IRD$3.67+0.27%

ResistanceSupportVol 14Insider sell

Vol MA14 1.04M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Opus Genetics, Inc.PHARMACEUTICAL PREPARATIONSwww.opusgtx.com ↗

Price3.67

Change+0.27%

Gap+0.82%

Rel volume2.63×

Avg volume999.9K

Avg $ vol3.44M

SMA 203.44

SMA 503.80

SMA 2003.51

Price vs 50-3.46%

Price vs 200+4.58%

MA stackmixed

50/200 cross—

Supertrendup · 2.98

RSI (14)51

MACD hist0.06

MACD crossbull · 8d

Stoch %K / %D75 / 76

ADX (14)19

+DI / −DI23 / 17

RSI divergence—

MACD divergence—

ATR %+6.84%

ADR %7.09%

52w high5.75

52w low1.06

From 52w high-36.17%

Above 52w low+246.23%

New 52w highNo

SqueezeOff

Bollinger width32.62%

%B0.71

Donchian pos74.56%

Donchian high3.96

Donchian low2.82

AVWAP (52w high)4.20

vs AVWAP high-12.59%

AVWAP (52w low)3.52

vs AVWAP low+4.31%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d2.63×

Avg vol (14d)1.04M

Avg vol (20d)999.9K

Avg $ vol (20d)3.44M

Market cap305.33M

RS 3m (vs SPY)-37.41%

RS 6m (vs SPY)+27.75%

RS line new highNo

Trend template3/8

Technical rank44.3

1 week+0.82%

1 month-6.38%

3 months-26.45%

6 months+21.93%

1 year+236.70%

YTD+73.11%

P/E-6.16

P/B-23.51

P/S21.51

P/FCF-8.66

EPS-0.8000

Div yield—

ROE381.88%

ROA-53.34%

Debt/Eq-0.09

Current12.19

EV/EBITDA-5.65

Gross margin—

Net margin-349.33%

Rev growth29.15%

EPS growth13.80%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value217.71M

Revenue755K

Net income-8.1M

Gross profit—

Free cash flow-35.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out82.57M

Employees28

ListedFri, Nov 6, 2020

Free float56.1M

Float %78.9%

Short interest10.27M

Days to cover12.5d

Short volume45.2%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.14 vs −$0.15

Last surprise+6.7% beat

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank44.3 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IRD

All disclosures →

No recent disclosed trades by Congress in IRD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IRD · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Gagnon Robert E. Chief Financial Officer · Common Stock · 2026-07-23	Sell	7.78K	$23K	2026-07-23	2026-07-27
Magrath George Chief Executive Officer · Common Stock · 2026-07-23	Sell	9.47K	$28K	2026-07-23	2026-07-27
SCHACHLE JOSEPH K Chief Operating Officer · Common Stock · 2026-07-23	Sell	4.64K	$14K	2026-07-23	2026-07-27
YERXA BENJAMIN R President · Common Stock · 2026-07-23	Sell	7.43K	$22K	2026-07-23	2026-07-27
Foundation Fighting Blindness Retinal Degeneration Fund Director · Common Stock · 2026-05-18	Sell	1.7M	$7.4M	2026-05-18	2026-05-20
Foundation Fighting Blindness, Inc. Director · Common Stock · 2026-05-18	Sell	1.7M	$7.4M	2026-05-18	2026-05-20
SCHACHLE JOSEPH K Chief Operating Officer · Common Stock · 2026-04-23	Sell	4.7K	$25K	2026-04-23	2026-04-27
Magrath George Chief Executive Officer · Common Stock · 2026-04-23	Sell	9.51K	$50K	2026-04-23	2026-04-27
Jayagopal Ashwath Chief Scientific & Dev. Ofc. · Common Stock · 2026-04-23	Sell	7.54K	$39K	2026-04-23	2026-04-27
YERXA BENJAMIN R President · Common Stock · 2026-04-23	Sell	7.47K	$39K	2026-04-23	2026-04-27

SEC filings

EDGAR filings in IRD · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.